The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman(University of Chicago), Clara D. Bloomfield(North Shore University Hospital), Eva Hellström‐Lindberg(Karolinska University Hospital), Anna Porwit(Lund University), Richard D. Brunning(University of Minnesota), Ayalew Tefferi(Mayo Clinic), Daniel A. Arber(University of Chicago), Michelle M. Le Beau(University of Chicago), Michael J. Borowitz(Johns Hopkins University), Jüergen Thiele(University of Cologne), Nancy L. Harris(World Resources Institute)
Cited by 4,412
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k